{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T12:28:08Z","timestamp":1777724888534,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1053\/j.ajkd.2021.06.016","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T23:49:06Z","timestamp":1626479346000},"page":"611-613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":152,"title":["ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine"],"prefix":"10.1053","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6508-9972","authenticated-orcid":false,"given":"Muhammad Tariq","family":"Shakoor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark P.","family":"Birkenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2021.06.016_bib1","unstructured":"Johns Hopkins University Coronavirus Resource Center. COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. June 1, 2021. https:\/\/coronavirus.jhu.edu\/map.html"},{"issue":"27","key":"10.1053\/j.ajkd.2021.06.016_bib2","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1053\/j.ajkd.2021.06.016_bib3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1053\/j.ajkd.2021.06.016_bib4","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/jama.2021.1967","article-title":"Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US-December 14, 2020-January 18, 2021","volume":"325","author":"Shimabukuro","year":"2021","journal-title":"JAMA"},{"issue":"4","key":"10.1053\/j.ajkd.2021.06.016_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.15585\/mmwr.mm7004e1","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine - United States, December 21, 2020-January 10, 2021","volume":"70","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"10.1053\/j.ajkd.2021.06.016_bib6","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.2215\/CJN.02500317","article-title":"ANCA glomerulonephritis and\u00a0vasculitis","volume":"12","author":"Jennette","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2021.06.016_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/RHU.0b013e3181b55fe4","article-title":"ANCA-associated vasculitis following influenza vaccination: causal association or mere coincidence?","volume":"15","author":"Birck","year":"2009","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"4","key":"10.1053\/j.ajkd.2021.06.016_bib8","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10067-015-3073-0","article-title":"Viral RNA in the influenza vaccine may have contributed to the development of ANCA-associated vasculitis in a patient following immunisation","volume":"35","author":"Jeffs","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1053\/j.ajkd.2021.06.016_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/RHU.0b013e3181b56177","article-title":"Post-influenza vaccination vasculitides: a possible new entity","volume":"15","author":"Zafrir","year":"2009","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"2","key":"10.1053\/j.ajkd.2021.06.016_bib10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000354084","article-title":"Antineutrophil cytoplasmic antibody vasculitis associated with influenza vaccination","volume":"38","author":"Duggal","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.ajkd.2021.06.016_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13223-017-0222-9","article-title":"MPO-ANCA associated vasculitis with mononeuritis multiplex following influenza vaccination","volume":"13","author":"Eindhoven","year":"2017","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"2","key":"10.1053\/j.ajkd.2021.06.016_bib12","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.kint.2021.05.017","article-title":"ANCA glomerulonephritis after the Moderna COVID-19 vaccination","volume":"100","author":"Sekar","year":"2021","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2021.06.016_bib13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2174\/1573397113666170517155443","article-title":"Vasculitis following influenza vaccination: a review of the literature","volume":"13","author":"Watanabe","year":"2017","journal-title":"Curr Rheumatol Rev"},{"issue":"5","key":"10.1053\/j.ajkd.2021.06.016_bib14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/nep.12416","article-title":"Randomized trial investigating the safety and efficacy of influenza vaccination in patients with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"20","author":"Jeffs","year":"2015","journal-title":"Nephrology (Carlton)"},{"issue":"4","key":"10.1053\/j.ajkd.2021.06.016_bib15","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/BOR.0000000000000068","article-title":"Infectious triggers for vasculitis","volume":"26","author":"van Timmeren","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"10.1053\/j.ajkd.2021.06.016_bib16","article-title":"Anti-neutrophilic cytoplasmic antibody (ANCA) vasculitis presented as pulmonary hemorrhage in a positive COVID-19 patient: a case report","volume":"12","author":"Hussein","year":"2020","journal-title":"Cureus"},{"issue":"11","key":"10.1053\/j.ajkd.2021.06.016_bib17","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.ekir.2020.08.012","article-title":"De novo ANCA-associated vasculitis with glomerulonephritis in COVID-19","volume":"5","author":"Uppal","year":"2020","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1053\/j.ajkd.2021.06.016_bib18","first-page":"239","article-title":"Newly diagnosed glomerulonephritis during COVID-19 infection undergoing immunosuppression therapy, a case report","volume":"14","author":"Moeinzadeh","year":"2020","journal-title":"Iran J Kidney Dis"},{"issue":"8","key":"10.1053\/j.ajkd.2021.06.016_bib19","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00296-021-04914-3","article-title":"ANCA-associated vasculitis after COVID-19","volume":"41","author":"Izci Duran","year":"2021","journal-title":"Rheumatol Int"},{"key":"10.1053\/j.ajkd.2021.06.016_bib20","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1136\/annrheumdis-2020-218009","article-title":"Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19","volume":"79","author":"Vlachoyiannopoulos","year":"2020","journal-title":"Ann Rheum Dis"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638621007423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638621007423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:39:54Z","timestamp":1759462794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638621007423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0272638621007423"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2021.06.016","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2021.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}